Status:

COMPLETED

COVID-19 Vaccine Messaging, Part 1

Lead Sponsor:

Yale University

Conditions:

Vaccination

COVID-19

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study tests different messages about vaccinating against COVID-19 once the vaccine becomes available. Participants are randomized to 1 of 12 arms, with one control arm and one baseline arm. We wi...

Eligibility Criteria

Inclusion

  • At least 18 years of age
  • US resident

Exclusion

  • Younger than 18 years of age
  • Non-US resident
  • Do not consent

Key Trial Info

Start Date :

July 3 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 8 2020

Estimated Enrollment :

4000 Patients enrolled

Trial Details

Trial ID

NCT04460703

Start Date

July 3 2020

End Date

July 8 2020

Last Update

May 5 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Yale University

New Haven, Connecticut, United States, 06510

COVID-19 Vaccine Messaging, Part 1 | DecenTrialz